Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 10201-10250 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT04396418
Stroke Prevention and Rhythm Control Therapy STEEER-AF
NAActive, not recruiting
1,732 participants
Started: Dec 29, 2021 · Completed: Dec 30, 2025
1 condition2 sponsors70 locations
NCT05144997
Lorlatinib Continuation Study
PHASE4Active, not recruiting
74 participants
Started: Dec 28, 2021 · Completed: Dec 28, 2026
2 conditions1 sponsor35 locations
NCT05026905
A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic Cancer
PHASE2Active, not recruiting
66 participants
Started: Dec 28, 2021 · Completed: Dec 31, 2027
1 condition5 sponsors4 locations
NCT05171569
Post Discharge After Surgery Virtual Care With Remote Automated Monitoring Technology-3 Trial
NAActive, not recruiting
2,500 participants
Started: Dec 28, 2021 · Completed: May 31, 2025
1 condition2 sponsors2 locations
NCT05139602
A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy
PHASE2Active, not recruiting
210 participants
Started: Dec 28, 2021 · Completed: Jan 31, 2026
1 condition1 sponsor54 locations
NCT05167071
HBM4003 Combine With Toripalimab in Patients With Advanced NEN and Other Solid Tumors Study
PHASE1Active, not recruiting
53 participants
Started: Dec 28, 2021 · Completed: Jun 30, 2026
3 conditions1 sponsor1 location
NCT02403505
Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating CEA Positive Rectal Cancer
PHASE1Active, not recruiting
20 participants
Started: Dec 28, 2021 · Completed: Feb 28, 2026
1 condition2 sponsors1 location
NCT05164094
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults
PHASE1/PHASE2Active, not recruiting
867 participants
Started: Dec 28, 2021 · Completed: Oct 5, 2026
1 condition1 sponsor65 locations
NCT05164653
Program of Angiotensin-Neprilysin Inhibition in Admitted Patients With Worsening Heart Failure (PREMIER)
PHASE4Active, not recruiting
400 participants
Started: Dec 27, 2021 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT05262426
Developing mHealth to Promote PrEP Use Among Thai Young Vulnerable Adolescents and Emerging Adults
NAActive, not recruiting
145 participants
Started: Dec 27, 2021 · Completed: Jul 31, 2026
1 condition4 sponsors3 locations
NCT05231005
Fourth BNT162b2 COVID-19 Vaccine Dose
PHASE4Active, not recruiting
1,000 participants
Started: Dec 27, 2021 · Completed: Jun 26, 2024
1 condition1 sponsor1 location
NCT05160922
Crizotinib Continuation Clinical Study
PHASE4Active, not recruiting
27 participants
Started: Dec 27, 2021 · Completed: Mar 21, 2028
3 conditions1 sponsor13 locations
NCT05180526
Assessment of Safety , Clinical Efficacy with QLETLI in Non-infectious Uveitis (UV)
PHASE4Active, not recruiting
60 participants
Started: Dec 27, 2021 · Completed: Dec 30, 2024
1 condition1 sponsor7 locations
NCT05215639
A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy in Switzerland and Austria Receiving Oral Venetoclax Tablets
N/AActive, not recruiting
125 participants
Started: Dec 27, 2021 · Completed: Nov 30, 2025
1 condition1 sponsor19 locations
NCT05105971
Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumor Patients in China
PHASE1Active, not recruiting
30 participants
Started: Dec 23, 2021 · Completed: Nov 14, 2024
1 condition1 sponsor1 location
NCT05174910
Investigation of the Benefit of Using an Autologous Platelet-rich Fibrin Matrix (Obsidian ASG®) for Treatment of Anastomosis During Rectal Surgery
NAActive, not recruiting
250 participants
Started: Dec 23, 2021 · Completed: Dec 31, 2024
1 condition5 sponsors13 locations
NCT05216016
Minnesota RETAIN Phase 2 (Sub-study)
NAActive, not recruiting
5,200 participants
Started: Dec 23, 2021 · Completed: May 31, 2026
3 conditions7 sponsors1 location
NCT05147558
A Study of Pembrolizumab With Lenvatinib in Women With Advanced Uterine Carcinosarcoma
PHASE2Active, not recruiting
40 participants
Started: Dec 23, 2021 · Completed: Dec 23, 2025
2 conditions2 sponsors7 locations
NCT05102279
Analysis of Urine Composition Saturation and Dietary Intervention in Subjects Without Urinary Calculi
NAActive, not recruiting
10 participants
Started: Dec 23, 2021 · Completed: Dec 30, 2024
3 conditions1 sponsor1 location
NCT05108428
Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma
EARLY_PHASE1Active, not recruiting
20 participants
Started: Dec 23, 2021 · Completed: Oct 31, 2026
1 condition3 sponsors1 location
NCT05218668
Rho Kinase Inhibitor in Amyotrophic Lateral Sclerosis (REAL)
PHASE2Active, not recruiting
40 participants
Started: Dec 22, 2021 · Completed: Jan 31, 2029
1 condition1 sponsor12 locations
NCT05132166
A Randomized Phase II Study to Compare the Potential Long-Lasting Positive Effect of Decidual Stromal Cells to the Best Available Treatment in Graft Versus Host Disease
PHASE2Active, not recruiting
50 participants
Started: Dec 22, 2021 · Completed: Apr 26, 2026
1 condition1 sponsor1 location
NCT05207098
A Study of Neurocognitive Tests and Questionnaires for People With Head and Neck Cancer Who Are Undergoing Radiation Therapy
N/AActive, not recruiting
54 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor7 locations
NCT05071209
Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors
PHASE1/PHASE2Active, not recruiting
31 participants
Started: Dec 22, 2021 · Completed: Nov 22, 2025
8 conditions1 sponsor29 locations
NCT05145907
Study to Evaluate Safety and Efficacy of TJ107 Combine With PD-1 in Patients With Solid Tumors
PHASE2Active, not recruiting
133 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2024
2 conditions1 sponsor20 locations
NCT05269394
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)
PHASE2/PHASE3Active, not recruiting
197 participants
Started: Dec 22, 2021 · Completed: Jul 31, 2028
3 conditions5 sponsors38 locations
NCT05054439
A Clinical Study of SI-B001 in Combination With Paclitaxel in the Treatment of Recurrent and Metastatic HNSCC
PHASE2Active, not recruiting
42 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor7 locations
NCT06571955
ACL Reconstruction with a New Generation of LARS Artificial Ligament
NAActive, not recruiting
40 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04685590
Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD) Study
PHASE2Active, not recruiting
48 participants
Started: Dec 22, 2021 · Completed: Jan 31, 2029
2 conditions3 sponsors5 locations
NCT05153772
Targeted Alpha-emitter Therapy of PRRT Naïve and Previous PRRT Neuroendocrine Tumor Patients
PHASE2Active, not recruiting
69 participants
Started: Dec 21, 2021 · Completed: Oct 31, 2028
1 condition2 sponsors4 locations
NCT05228470
A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.
PHASE2Active, not recruiting
39 participants
Started: Dec 21, 2021 · Completed: Oct 31, 2025
11 conditions1 sponsor15 locations
NCT04958811
Tiragolumab With Atezolizumab Plus Bevacizumab in Previously-Treated Advanced Non-squamous NSCLC
PHASE2Active, not recruiting
29 participants
Started: Dec 21, 2021 · Completed: Dec 31, 2025
1 condition2 sponsors2 locations
NCT05165979
Cohort Study for the Assessment of Long-term Impact of COVID-19 Among Moderate and Severe COVID-19 Patients in Brazil
N/AActive, not recruiting
650 participants
Started: Dec 21, 2021 · Completed: Jul 1, 2024
4 conditions1 sponsor24 locations
NCT05068388
Effect of Oral (Z)-Endoxifen in Premenopausal Women With Measurable Breast Density
PHASE2Active, not recruiting
240 participants
Started: Dec 21, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05031078
Assessing Durable Antibody Response to HPV Vaccination
PHASE4Active, not recruiting
17 participants
Started: Dec 21, 2021 · Completed: May 31, 2026
1 condition1 sponsor2 locations
NCT05130827
Study of Plinabulin and Pegfilgrastim in People With Multiple Myeloma Undergoing an Autologous Hematopoietic Stem Cell Transplant (AHCT)
PHASE2Active, not recruiting
17 participants
Started: Dec 21, 2021 · Completed: Nov 30, 2025
1 condition2 sponsors7 locations
NCT05141201
SAPHNELO Systemic Lupus Erythematosus Japan Post-Marketing Surveillance (PMS)
N/AActive, not recruiting
1,620 participants
Started: Dec 21, 2021 · Completed: Nov 30, 2025
1 condition1 sponsor47 locations
NCT04905069
Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer Being Treated With Stereotactic Body Radiotherapy
NAActive, not recruiting
500 participants
Started: Dec 21, 2021 · Completed: Apr 30, 2030
1 condition1 sponsor30 locations
NCT04919226
Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE
PHASE3Active, not recruiting
259 participants
Started: Dec 21, 2021 · Completed: Sep 30, 2027
1 condition1 sponsor42 locations
NCT05197036
A Global Clinical Study Investigating the Safety and Effectiveness of Smith and Nephew's Porous Knee System in Patients Who Need a Total Knee Replacement Due to Degenerative Arthritis, Post-traumatic Arthritis or Inflammatory Arthritis
N/AActive, not recruiting
299 participants
Started: Dec 21, 2021 · Completed: Dec 25, 2028
3 conditions1 sponsor21 locations
NCT04533750
Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin
PHASE1Active, not recruiting
42 participants
Started: Dec 20, 2021 · Completed: Dec 31, 2025
18 conditions2 sponsors27 locations
NCT06881329
Epigenome-wide DNA Methylation Profiling in Aneurysmal Subarachnoid Hemorrhage and Delayed Ischemic Neurologic Deficit
N/AActive, not recruiting
61 participants
Started: Dec 20, 2021 · Completed: Dec 31, 2025
4 conditions2 sponsors1 location
NCT05071963
INSPIRE Pipeline™ Shield Post Approval Study
N/AActive, not recruiting
246 participants
Started: Dec 20, 2021 · Completed: Apr 30, 2028
1 condition1 sponsor16 locations
NCT04770753
A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT)
PHASE3Active, not recruiting
194 participants
Started: Dec 20, 2021 · Completed: Dec 31, 2028
2 conditions1 sponsor68 locations
NCT04819100
A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)
PHASE3Active, not recruiting
152 participants
Started: Dec 20, 2021 · Completed: May 31, 2028
1 condition2 sponsors211 locations
NCT05157386
Physical Exercise as Adjunctive Therapy for Affective Disorder and Anxiety
N/AActive, not recruiting
50 participants
Started: Dec 20, 2021 · Completed: Dec 31, 2025
14 conditions2 sponsors1 location
NCT06191172
The Effect of Person-Centered Care Applied to Patients With Dementia on Nutritional Status
NAActive, not recruiting
55 participants
Started: Dec 20, 2021 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT04974216
Study of Tafasitamab and Lenalinomide Associated to Rituximab in Frontline Diffuse Large B-Cell Lymphoma Patients of 80 y/o or Older
PHASE2Active, not recruiting
71 participants
Started: Dec 20, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor15 locations
NCT05252715
Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 5 Months
PHASE3Active, not recruiting
1,200 participants
Started: Dec 18, 2021 · Completed: Sep 18, 2024
1 condition1 sponsor2 locations
NCT05192382
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2)
PHASE3Active, not recruiting
111 participants
Started: Dec 17, 2021 · Completed: Jan 31, 2028
1 condition1 sponsor57 locations